510(k) Report

510(k) · Cleared

Cleared

Distalock Tibial IM Nail System

K132830510(k) TraditionalCleared Jan 6, 2014118-day reviewClass II21 CFR 888.3020

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dgimed Ortho, Inc. · HSB Rod, Fixation, Intramedullary And Accessories

Cleared on Jan 6, 2014 as substantially equivalent to K051557 (Smith & Nephew, Inc., 2005) after a 118-day review. Its family tree reaches back 3 generations to 1995.

Decided
Jan 6, 2014
Review
118 days
Class
Class II
Product code
HSB
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K951740 (1995). 9 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2004: 1 other ancestor1998: 2 other ancestors2001: 2 other ancestors1999: 1 other ancestorK951740 · Intramedulary Fixation Rod · Acu Med, Inc. · 1995 · recalledK032722 · Trigen Straight Humeral Nail System · Smith & Nephew, Inc. · 2003K051557 · Trigen Retrograde Femoral, Supracondylar and Tibial Nails · Smith & Nephew, Inc. · 200519952000200520102015
  1. Root · 3 generations backK951740 Intramedulary Fixation RodAcu Med, Inc. · 1995 · Recalled
  2. 2 generations backK032722 Trigen Straight Humeral Nail SystemSmith & Nephew, Inc. · 2003
  3. 1 generation backK051557 Trigen Retrograde Femoral, Supracondylar and Tibial NailsSmith & Nephew, Inc. · 2005
  4. This deviceK132830 Distalock Tibial IM Nail SystemDgimed Ortho, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K951740Intramedulary Fixation RodAcu Med, Inc.19951
−2K032722Trigen Straight Humeral Nail SystemSmith & Nephew, Inc.2003—
−1K051557Trigen Retrograde Femoral, Supracondylar and Tibial NailsSmith & Nephew, Inc.2005—
0 (this device)K132830Distalock Tibial IM Nail SystemDgimed Ortho, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199820
199910
200120
200410
FIG. 1 — Lineage of K132830, 1995–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HSB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HSB device

  1. #1 K200869 Gamma3 Systemscore 19.8 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051557Trigen Retrograde Femoral, Supracondylar and Tibial Nails
Summary page 1
…Class I1lPer 21 CFR§:888.3020 P,rodubct Code HSB Predicate Device: Smith'& Nephew TriGen Tibial NafI System K051 557 Manufacturer: DGIMVEDtOrtho, 1nc. 12400 Whitewater Drive,;Suite 2…
Smith & Nephew, Inc.2005—

Also cleared against K051557: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 8.1 years on median.
  • 4 of the 9 ancestors have a recall of any class.
  • 5 other devices also cite its predicate K051557.

How does its category compare?

All HSB devices

HSB Rod, Fixation, Intramedullary And Accessories: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · HSB

15in 2025

2007: 82008: 112009: 182010: 142011: 162012: 172013: 182014: 192015: 222016: 82017: 232018: 172019: 132020: 172021: 102022: 122023: 112024: 132025: 152026 (partial year): 18
2007high 23 (2017) · low 8 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HSB

106in 2025

2007: 68 days median2008: 57 days median2009: 86 days median2010: 117 days median2011: 78 days median2012: 112 days median2013: 105 days median2014: 147 days median2015: 111 days median2016: 124 days median2017: 119 days median2018: 134 days median2019: 132 days median2020: 112 days median2021: 94 days median2022: 172 days median2023: 162 days median2024: 195 days median2025: 106 days median2026 (partial year): 151 days median
2007high 195 (2024) · low 57 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HSB

18in 2025

2008: 92009: 812010: 182011: 22012: 72013: 142014: 32015: 32016: 62017: 662018: 562019: 62020: 62021: 22022: 12023: 12024: 12025: 182026 (partial year): 1
2007high 81 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HSB

2,911in 2025

2007: 1622008: 1842009: 3342010: 4542011: 6622012: 1,0792013: 1,7732014: 1,4742015: 1,6712016: 1,9202017: 1,4472018: 3,5262019: 2,5172020: 3,2992021: 4,1112022: 2,7332023: 2,2192024: 2,8692025: 2,911
2007high 4,111 (2021) · low 162 (2007)2025

MAUDE reports naming product code HSB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078680162
200811579184
2009188681334
20101411718454
201116782662
20121711271,079
201318105141,773
20141914731,474
20152211131,671
2016812461,920
201723119661,447
201817134563,526
20191313262,517
20201711263,299
2021109424,111
20221217212,733
20231116212,219
20241319512,869
202515106182,911
2026181511—

What is it indicated for?

Intended to stabilize shaft fractures between the proximal and distal third of the tibia. Indications include transverse, comminuted, spiral, oblique, and segmental fractures. The Tibial Nail may also be used for treatment of mal-unions as well as prophylactic nailings of impending pathological fractures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K132830: Distalock Tibial IM Nail System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K132830

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026